Antigen-specific chemokine CCL3 as a biomarker for distinguishing between recent and remote tuberculosis infection

Mpande CAM, Musvosvi M, Rozot V, et al. Antigen-specific T-cell activation distinguishes between recent and remote tuberculosis infection. Am J Respir Crit Care Med. 2021;203(12):1556–65.

Article  CAS  PubMed  PubMed Central  Google Scholar 

MacNeil A, Glaziou P, Sismanidis C, et al. Global epidemiology of tuberculosis and progress toward achieving global targets-2017. Morb Mortal Wkly Rep. 2019;68(11):263–6.

Article  Google Scholar 

Mpande CAM, Rozot V, Mosito B, et al. Immune profiling of Mycobacterium tuberculosis-specific T cells in recent and remote infection. EBioMedicine. 2021. https://doi.org/10.1016/j.ebiom.2021.103233.

Article  PubMed  PubMed Central  Google Scholar 

Halliday A, Whitworth H, Kottoor SH, et al. Stratification of latent Mycobacterium tuberculosis infection by cellular immune profiling. J Infect Dis. 2017;215(9):1480–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Erkens CGM, Slump E, Verhagen M, et al. Risk of developing tuberculosis disease among persons diagnosed with latent tuberculosis infection in the Netherlands. Eur Respir J. 2016;48(5):1420–8.

Article  PubMed  Google Scholar 

Behr MA, Edelstein PH, Ramakrishnan L. Is Mycobacterium tuberculosis infection life long? BMJ. 2019. https://doi.org/10.1136/bmj.l5770.

Article  PubMed  PubMed Central  Google Scholar 

Ault RC, Headley CA, Hare AE, et al. Blood RNA signatures predict recent tuberculosis exposure in mice, macaques and humans. Sci Rep. 2020. https://doi.org/10.1038/s41598-020-73942-z.

Article  PubMed  PubMed Central  Google Scholar 

McCormick S, Shaler CR, Xing Z. Pulmonary mucosal dendritic cells in T-cell activation: implications for TB therapy. Expert Rev Respir Med. 2011;5(1):75–85.

Article  CAS  PubMed  Google Scholar 

Vasiliu A, Martinez L, Gupta RK, et al. Tuberculosis prevention: current strategies and future directions. Clin Microbiol Infect. 2024;30(9):1123–30.

Article  PubMed  Google Scholar 

Migliori GB, Wu SJ, Matteelli A, et al. Clinical standards for the diagnosis, treatment and prevention of TB infection. Int J Tuberc Lung Dis. 2022;26(3):190–205.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harding E. WHO global progress report on tuberculosis elimination (vol 8, pg 19, 2020). Lancet Respir Med. 2020;8(1):19.

Article  PubMed  Google Scholar 

Haas MK, Belknap RW. Diagnostic tests for latent tuberculosis infection. Clin Chest Med. 2019;40(4):829–37.

Article  PubMed  Google Scholar 

Pai M, Denkinger CM, Kik SV, et al. Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin Microbiol Rev. 2014;27(1):3–20.

Article  PubMed  PubMed Central  Google Scholar 

Zhang H, Guan W, Zhou J. Advances in the diagnosis of latent tuberculosis infection. Infect Drug Resist. 2025;18:483–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Flynn JL, Chan J. Immune cell interactions in tuberculosis. Cell. 2022;185(25):4682–702.

Article  CAS  PubMed  Google Scholar 

Vats D, Rani G, Arora A, et al. Tuberculosis and T cells: impact of T cell diversity in tuberculosis infection. Tuberculosis. 2024. https://doi.org/10.1016/j.tube.2024.102567.

Article  PubMed  Google Scholar 

Jasenosky LD, Scriba TJ, Hanekom WA, et al. T cells and adaptive immunity to Mycobacterium tuberculosis in humans. Immunol Rev. 2015;264(1):74–87.

Article  CAS  PubMed  Google Scholar 

Awoniyi DO, Teuchert A, Sutherland JS, et al. Evaluation of cytokine responses against novel Mtb antigens as diagnostic markers for TB disease. J Infect. 2016;73(3):219–30.

Article  PubMed  Google Scholar 

Duffy D, Rouilly V, Braudeau C, et al. Standardized whole blood stimulation improves immunomonitoring of induced immune responses in multi-center study. Clin Immunol. 2017;183:325–35.

Article  CAS  PubMed  Google Scholar 

Ravesloot-Chávez MM, Van Dis E, Stanley SA. The innate immune response to Mycobacterium tuberculosis infection. Annu Rev Immunol. 2021;39:611–637. https://doi.org/10.1146/annurev-immunol-093019-010426

Article  CAS  PubMed  Google Scholar 

Domingo-Gonzalez R, Prince O, Cooper A, et al. Cytokines and chemokines in Mycobacterium tuberculosis infection. Microbiol Spectr. 2016. https://doi.org/10.1128/microbiolspec.TBTB2-0018-2016.

Article  PubMed  Google Scholar 

Ren W, Ma Z, Li Q, et al. Antigen-specific chemokine profiles as biomarkers for detecting Mycobacterium tuberculosis infection. Front Immunol. 2024. https://doi.org/10.3389/fimmu.2024.1359555.

Article  PubMed  PubMed Central  Google Scholar 

Yates TA, Khan PY, Knight GM, et al. The transmission of Mycobacterium tuberculosis in high burden settings. Lancet Infect Dis. 2016;16(2):227–38.

Article  PubMed  Google Scholar 

Singh V. Tuberculosis treatment-shortening. Drug Discov Today. 2024;29(5): 103955.

Article  CAS  PubMed  Google Scholar 

Nasiri MJ, Pormohammad A, Goudarzi H, et al. Latent tuberculosis infection in transplant candidates: a systematic review and meta-analysis on TST and IGRA. Infection. 2019;47(3):353–61.

Article  PubMed  Google Scholar 

Nogueira BMF, Rangel F, Andrade AMS, et al. Predictive markers of incident tuberculosis in close contacts in Brazil and India. J Infect Dis. 2025. https://doi.org/10.1093/infdis/jiae642.

Article  PubMed  Google Scholar 

Herrera M, Keynan Y, Lopez L, et al. Cytokine/chemokine profiles in people with recent infection by Mycobacterium tuberculosis. Front Immunol. 2023. https://doi.org/10.3389/fimmu.2023.1129398.

Article  PubMed  PubMed Central  Google Scholar 

Zhang YY, Yoneyama H, Wang Y, et al. Mobilization of dendritic cell precursors into the circulation by administration of MIP-1α in mice. J Natl Cancer Inst. 2004;96(3):201–9.

Article  CAS  PubMed  Google Scholar 

He S, Cao Q, Yoneyama H, et al. MIP-3α and MIP-1α rapidly mobilize dendritic cell precursors into the peripheral blood. J Leukoc Biol. 2008;84(6):1549–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schaller TH, Batich KA, Suryadevara CM, et al. Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3. Expert Rev Clin Immunol. 2017;13(11):1049–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kang TG, Park HJ, Moon J, et al. Enriching CCL3 in the tumor microenvironment facilitates T cell responses and improves the efficacy of anti-PD-1 therapy. Immune Netw. 2021. https://doi.org/10.4110/in.2021.21.e23.

Article  PubMed  PubMed Central  Google Scholar 

Yao S, Huang D, Chen CY, et al. CD4+ t cells contain early extrapulmonary tuberculosis (TB) dissemination and rapid TB progression and sustain multieffector functions of CD8+ t and CD32- lymphocytes: mechanisms of CD4+ t cell immunity. J Immunol. 2014;192(5):2120–32.

Article 

Comments (0)

No login
gif